|
⚲
|
| Keyboard |
| McNay Joseph C
✚
|
|
|---|---|
| CIK # | 0001257674 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0001257674] | |
| SC 13D | [0001257674] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| McNay Joseph C | Regenerx Biopharmaceuticals Inc | [2014-12-29] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| McNay Joseph C | |
| Regenerx Biopharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Regenerx Biopharmaceuticals Inc RGRX
Stock Option (Right to Buy) · derivative
|
2022-05-17 | Grant | 290,000 | $0.00 | |
|
Regenerx Biopharmaceuticals Inc RGRX
Stock Option (right to buy) · derivative
|
2021-08-02 | Grant | 290,000 | $0.00 | |
|
Regenerx Biopharmaceuticals Inc RGRX
Stock Option (right to buy) · derivative
|
2020-06-10 | Grant | 250,000 | $0.00 | |
|
Regenerx Biopharmaceuticals Inc RGRX
Stock Option (right to buy) · derivative
|
2019-05-15 | Grant | 250,000 | $0.00 | |
|
Regenerx Biopharmaceuticals Inc RGRX
Common Stock Warrant (right to buy) · derivative
|
2019-05-13 | Buy | $0.00 | ||
|
Regenerx Biopharmaceuticals Inc RGRX
Convertible Promissory Note (right to buy) · derivative
|
2019-05-13 | Buy | 78,125 | $12,500.00 | 976,562,500 |
|
Regenerx Biopharmaceuticals Inc RGRX
Convertible Promissory Note (right to buy) · derivative
|
2019-02-27 | Buy | 78,125 | $12,500.00 | 976,562,500 |
|
Regenerx Biopharmaceuticals Inc RGRX
Common Stock Warrant (right to buy) · derivative
|
2019-02-27 | Buy | $0.00 | ||
|
Regenerx Biopharmaceuticals Inc RGRX
Common Stock
|
2019-01-06 | Conversion | 522,280 | $0.06 | 31,337 |
|
Regenerx Biopharmaceuticals Inc RGRX
Convertible Promissory Note (right to buy) · derivative
|
2019-01-06 | Conversion | 522,280 | ||
|
Regenerx Biopharmaceuticals Inc RGRX
Common Stock
|
2018-09-11 | Conversion | 2,089,120 | $0.06 | 125,347 |
|
Regenerx Biopharmaceuticals Inc RGRX
Convertible Promissory Note (right to buy) · derivative
|
2018-09-11 | Conversion | 2,089,120 | ||
|
Regenerx Biopharmaceuticals Inc RGRX
Stock Option (Right to Buy) · derivative
|
2018-07-17 | Grant | 200,000 | $0.21 | 42,000 |
|
Regenerx Biopharmaceuticals Inc RGRX
Convertible Promissory Note (right to buy) · derivative
|
2018-07-05 | Conversion | 1,044,560 | ||
|
Regenerx Biopharmaceuticals Inc RGRX
Common Stock
|
2018-07-05 | Conversion | 1,044,560 | $0.06 | 62,674 |
|
Regenerx Biopharmaceuticals Inc RGRX
Common Stock
|
2018-03-29 | Conversion | 1,044,560 | $0.06 | 62,674 |
|
Regenerx Biopharmaceuticals Inc RGRX
Convertible Promissory Note (right to buy) · derivative
|
2018-03-29 | Conversion | 1,044,560 | ||
|
Regenerx Biopharmaceuticals Inc RGRX
Convertible Promissory Note (right to buy) · derivative
|
2017-10-19 | Conversion | 417,824 | ||
|
Regenerx Biopharmaceuticals Inc RGRX
Common Stock Warrant (right to buy) · derivative
|
2017-10-19 | Option exercise | 66,667 | $0.00 | |
|
Regenerx Biopharmaceuticals Inc RGRX
Common Stock
|
2017-10-19 | Option exercise | 66,667 | $0.15 | 10,000 |
| showing 20 of 35 most recent transactions | |||||